Normative Data for Brainstem Structures, the Midbrain-to-Pons Ratio, and the Magnetic Resonance Parkinsonism Index

References

1. 1.↵
   1. Oba H,
   2. Yagishita A,
   3. Terada H, et al

   . New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005;64:2050–55 doi:10.1212/01.WNL.0000165960.04422.D0 pmid:15985570

   Abstract/FREE Full Text
2. 2.↵
   1. Quattrone A,
   2. Nicoletti G,
   3. Messina D, et al

   . MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008;246:214–21 doi:10.1148/radiol.2453061703 pmid:17991785

   CrossRefPubMed
3. 3.↵
   1. Chougar L,
   2. Pyatigorskaya N,
   3. Degos B, et al

   . The role of magnetic resonance imaging for the diagnosis of atypical parkinsonism. Front Neurol 2020;11:665 doi:10.3389/fneur.2020.00665 pmid:32765399

   CrossRefPubMed
4. 4.↵
   1. Quattrone A,
   2. Morelli M,
   3. Nigro S, et al

   . A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson’s disease. Parkinsonism Relat Disord 2018;54:3–8 doi:10.1016/j.parkreldis.2018.07.016 pmid:30068492

   CrossRefPubMed
5. 5.↵
   1. Longoni G,
   2. Agosta F,
   3. Kostić VS, et al

   . MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson’s disease. Mov Disord 2011;26:247–55 doi:10.1002/mds.23293 pmid:21412831

   CrossRefPubMed
6. 6.↵
   1. Morelli M,
   2. Arabia G,
   3. Salsone M, et al

   . Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease. Mov Disord 2011;26:527–33 doi:10.1002/mds.23529 pmid:21287599

   CrossRefPubMed
7. 7.↵
   1. Nigro S,
   2. Morelli M,
   3. Arabia G, et al

   . Magnetic resonance parkinsonism index and midbrain to pons ratio: which index better distinguishes progressive supranuclear palsy patients with a low degree of diagnostic certainty from patients with Parkinson disease? Parkinsonism Relat Disord 2017;41:31–36 doi:10.1016/j.parkreldis.2017.05.002 pmid:28487107

   CrossRefPubMed
8. 8.↵
   1. Testa D,
   2. Monza D,
   3. Ferrarini M, et al

   . Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. Neurol Sci 2001;22:247–51 doi:10.1007/s100720100021 pmid:11731878

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Gilman S,
   2. Wenning GK,
   3. Low PA, et al

   . Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670–76 doi:10.1212/01.wnl.0000324625.00404.15 pmid:18725592

   Abstract/FREE Full Text
10. 10.↵
    1. Whitwell JL,
    2. Höglinger GU,
    3. Antonini A

    , et al. Movement Disorder Society-endorsed PSP Study Group. Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord 2017;32:955–71 doi:10.1002/mds.27038 pmid:28500751

    CrossRefPubMed
11. 11.↵
    1. Meissner WG,
    2. Fernagut PO,
    3. Dehay B, et al

    . Multiple system atrophy: recent developments and future perspectives. Mov Disord 2019;34:1629–42 doi:10.1002/mds.27894 pmid:31692132

    CrossRefPubMed
12. 12.↵
    1. Cosottini M,
    2. Ceravolo R,
    3. Faggioni L, et al

    . Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 2007;116:37–42 doi:10.1111/j.1600-0404.2006.00767.x pmid:17587253

    CrossRefPubMed
13. 13.↵
    1. Höglinger GU,
    2. Respondek G,
    3. Stamelou M, et al

    ; Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society Criteria. Mov Disord 2017;32:853–64 doi:10.1002/mds.26987 pmid:28467028

    CrossRefPubMed
14. 14.↵
    1. Mueller C,
    2. Hussl A,
    3. Krismer F, et al

    . The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism. Parkinsonism Relat Disord 2018;54:90–94 doi:10.1016/j.parkreldis.2018.04.005 pmid:29643007

    CrossRefPubMed
15. 15.↵
    1. Morelli M,
    2. Arabia G,
    3. Messina D, et al

    . Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson’s disease. Mov Disord 2014;29:488–95 doi:10.1002/mds.25821 pmid:24573655

    CrossRefPubMed
16. 16.↵
    1. Gröschel K,
    2. Kastrup A,
    3. Litvan I, et al

    . Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology 2006;66:949–50 doi:10.1212/01.wnl.0000203342.77115.bf pmid:16567726

    FREE Full Text
17. 17.↵
    1. Bacchi S,
    2. Chim I,
    3. Patel S

    . Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy. J Med Imaging Radiat Oncol 2018;62:21–31 doi:10.1111/1754-9485.12613 pmid:28432758

    CrossRefPubMed
18. 18.↵
    1. Brooks DJ,
    2. Seppi K

    ; Neuroimaging Working Group on MSA. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 2009;24:949–64 doi:10.1002/mds.22413 pmid:19306362

    CrossRefPubMed
19. 19.↵
    1. Sankhla CS,
    2. Patil KB,
    3. Sawant N, et al

    . Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients. Neurol India 2016;64:239–45 doi:10.4103/0028-3886.177611 pmid:26954800

    CrossRefPubMed
20. 20.↵
    1. Ahn JH,
    2. Kim M,
    3. Kim JS, et al

    . Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson’s syndrome. Parkinsonism Relat Disord 2019;66:80–86 doi:10.1016/j.parkreldis.2019.07.009 pmid:31307918

    CrossRefPubMed
21. 21.↵
    1. Möller L,
    2. Kassubek J,
    3. Südmeyer M, et al

    . Manual MRI morphometry in Parkinsonian syndromes. Mov Disord 2017;32:778–82 doi:10.1002/mds.26921 pmid:28150443

    CrossRefPubMed
22. 22.↵
    1. Kato N,
    2. Arai K,
    3. Hattori T

    . Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003;210:57–60 doi:10.1016/S0022-510X(03)00014-5 pmid:12736089

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Warmuth-Metz M,
    2. Naumann M,
    3. Csoti I, et al

    . Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 2001;58:1076–79 doi:10.1001/archneur.58.7.1076 pmid:11448296

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Armstrong MJ

    . Progressive supranuclear palsy: an update. Curr Neurol Neurosci Rep 2018;18:12 doi:10.1007/s11910-018-0819-5 pmid:29455271

    CrossRefPubMed
25. 25.↵
    1. Nigro S,
    2. Arabia G,
    3. Antonini A, et al

    . Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy. Eur Radiol 2017;27:2665–75 doi:10.1007/s00330-016-4622-x pmid:27761709

    CrossRefPubMed
26. 26.↵
    1. Mangesius S,
    2. Hussl A,
    3. Tagwercher S, et al

    . No effect of age, gender and total intracranial volume on brainstem MR planimetric measurements. Eur Radiol 2020;30:2802–08 doi:10.1007/s00330-019-06504-1 pmid:31953661

    CrossRefPubMed
27. 27.↵
    1. Cahill L

    . Why sex matters for neuroscience. Nat Rev Neurosci 2006;7:477–84 doi:10.1038/nrn1909 pmid:16688123

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Tannenbaum C,
    2. Ellis RP,
    3. Eyssel F, et al

    . Sex and gender analysis improves science and engineering. Nature 2019;575:137–46 doi:10.1038/s41586-019-1657-6 pmid:31695204

    CrossRefPubMed
29. 29.↵
    1. Jancke L,
    2. Liem F,
    3. Merillat S

    . Weak correlations between body height and several brain metrics in healthy elderly subjects. Eur J Neurosci 2019;50:3578–89 doi:10.1111/ejn.14501 pmid:31278790

    CrossRefPubMed
30. 30.↵
    1. Willette AA,
    2. Kapogiannis D

    . Does the brain shrink as the waist expands? Ageing Res Rev 2015;20:86–97 doi:10.1016/j.arr.2014.03.007 pmid:24768742

    CrossRefPubMed
31. 31.↵
    1. Håberg AK,
    2. Hammer TA,
    3. Kvistad KA, et al

    . Incidental intracranial findings and their clinical impact: the HUNT MRI study in a general population of 1006 participants between 50-66 years. PLoS One 2016;11:e0151080 doi:10.1371/journal.pone.0151080 pmid:26950220

    CrossRefPubMed
32. 32.↵
    1. Krokstad S,
    2. Langhammer A,
    3. Hveem K, et al

    . Cohort profile: the HUNT Study, Norway. Int J Epidemiol 2013;42:968–77 doi:10.1093/ije/dys095 pmid:22879362

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Honningsvåg LM,
    2. Linde M,
    3. Håberg A, et al

    . Does health differ between participants and non-participants in the MRI-HUNT study, a population-based neuroimaging study? The Nord-Trøndelag health studies 1984-2009. BMC Med Imaging 2012;12:23 doi:10.1186/1471-2342-12-23 pmid:22846223

    CrossRefPubMed
34. 34.↵
    1. Cohen J

    . Statistical Power Analysis for the Behavioral Sciences (2nd ed). Hillsdale, NJ: Lawrence Earlbaum Associate; 1988
35. 35.↵
    1. Swinscow TDV

    . Statistics at Square One. 9th ed. Revised by MJ Campbell. BMJ Publishing Group; 1996
36. 36.↵
    1. Koo TK,
    2. Li MY

    . A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15:155–63 doi:10.1016/j.jcm.2016.02.012 pmid:27330520

    CrossRefPubMed
37. 37.↵
    1. Miki Y,
    2. Foti SC,
    3. Asi YT, et al

    . Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain 2019;142:2813–27 doi:10.1093/brain/awz189 pmid:31289815

    CrossRefPubMed
38. 38.↵
    1. Xu J,
    2. Kobayashi S,
    3. Yamaguchi S, et al

    . Gender effects on age-related changes in brain structure. AJNR Am J Neuroradiol 2000;21:112–18 pmid:10669234

    Abstract/FREE Full Text
39. 39.↵
    1. Regitz-Zagrosek V

    . Sex and gender differences in health: Science & Society Series on Sex and Science. EMBO Rep 2012;13:596–603 doi:10.1038/embor.2012.87 pmid:22699937

    FREE Full Text
40. 40.↵
    1. Mahale RR,
    2. Krishnan S,
    3. Divya KP, et al

    . Gender differences in progressive supranuclear palsy. Acta Neurol Belg 2021 Feb 17. [Epub ahead of print] doi:10.1007/s13760-021-01599-0 pmid:33595832

    CrossRefPubMed
41. 41.↵
    1. Mueller SG,
    2. Weiner MW,
    3. Thal LJ, et al

    . The Alzheimer’s Disease Neuroimaging Initiative. Neuroimaging Clin N Am 2005;15:869–77.xi-xii doi:10.1016/j.nic.2005.09.008 pmid:16443497

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Huppertz HJ,
    2. Moller L,
    3. Sudmeyer M, et al

    . Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Mov Disord 2016;31:1506–17 doi:10.1002/mds.26715 pmid:27452874

    CrossRefPubMed
43. 43.↵
    1. Scherfler C,
    2. Gobel G,
    3. Muller C, et al

    . Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism. Neurology 2016;86:1242–49 doi:10.1212/WNL.0000000000002518 pmid:26935895

    Abstract/FREE Full Text